A novel immunization method to induce cytotoxic T-lymphocyte responses (CTL) against plasmid-encoded herpes simplex virus type-1 glycoprotein D

By Cruz P.E.   Khalil P.L.   Dryden T.D.   Chiou H.C.   Fink P.S.   Berberich S.J.   Bigley N.J.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1091-1099

Elsevier

Access to resources Recommend Favorite

DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2

By Bourne N.   Milligan G.N.   Schleiss M.R.   Bernstein D.I.   Stanberry L.R.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1230-1234

Elsevier

Access to resources Recommend Favorite

DNA immunization utilizing a herpes simplex virus type 2 myogenic DNA vaccine protects mice from mortality and prevents genital herpes

By Gebhard J.R.J.R.   Zhu J.   Cao X.   Minnick J.   Araneo A.B.A.  

Vaccine, Vol. 18, Iss. 17, 2000-03 ,pp. : 1837-1846

Elsevier

Access to resources Recommend Favorite

Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization

By Hsu S.-C.   Schadeck E.B.   Delmas A.   Shaw M.   Steward M.W.  

Vaccine, Vol. 14, Iss. 12, 1996-08 ,pp. : 1159-1166

Elsevier

Access to resources Recommend Favorite

Immunity induced by DNA immunization with herpes simplex virus type 2 glycoproteins B and C

By Mester J.C.   Twomey T.A.   Tepe E.T.   Bernstein D.I.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 875-883

Elsevier

Access to resources Recommend Favorite